HUGroup Holdings (4544) AI Stock Analysis

• Market Cap: $179.76B
• Dividend Yield: 4%
• Average Volume (3M): 305.38K
• Price to Earnings (P/E): 64.8
• Beta (1Y): 0.46
• Revenue Growth: 2.56%
• EPS Growth: N/A
• Country: JP
• Employees: 5,295
• Sector: Healthcare
• Sector Strength: 47
• Industry: Medical - Diagnostics & Research
• EPS (TTM): -0.58
• Shares Outstanding: 57,473,824
• 10 Day Avg. Volume: 237,800
• 30 Day Avg. Volume: 305,383
• PEG Ratio: -0.21
• Price to Book (P/B): 1.01
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 13.98
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $3,015.29
• Price Target Upside: -5.77% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 63 Neutral
• Price Target: ¥3,255.00 ▲(1.72%Upside)

HUGroup Holdings shows a balanced performance with a strong technical momentum and robust dividend yield, offset by a high P/E ratio and past cash flow volatility. The primary strengths are operational improvements and technical indicators, while high valuation and leverage risks are key considerations.

HUGroup Holdings Business Overview & Revenue Model

Company Description

H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

How the Company Makes Money

HUGroup Holdings generates revenue through a diversified business model centered around its healthcare services. The primary revenue streams include fees from clinical laboratory testing services, which are offered to hospitals, clinics, and medical institutions. Additionally, the company earns income from the provision of diagnostic imaging services and the sale of medical informatics solutions, which support healthcare providers in managing patient data and improving operational efficiency. HUGroup Holdings also benefits from consulting services that help medical facilities optimize their operations and implement advanced healthcare technologies. Strategic partnerships with healthcare institutions and research organizations further contribute to the company's earnings by expanding its service offerings and customer base.

HUGroup Holdings Financial Statement Overview

Summary

HUGroup Holdings is in a recovery phase with improving operating margins and a strong equity base. Revenue growth is modest, but EBIT and EBITDA margin recovery indicates operational improvements. Rising debt levels pose a potential risk, and cash flow management, despite improvements, remains a concern due to past volatility.

Income Statement

HUGroup Holdings has shown fluctuating revenue trends with a recent annual growth rate of 2.56%. Gross profit margins have been relatively stable, averaging around 27% over the years, but there was a significant dip in net income during 2024. The company has managed to recover its EBIT and EBITDA margins in 2025, indicating some operational recovery.

Balance Sheet

The company's balance sheet reflects strong equity, with a moderate debt-to-equity ratio of 0.63 in 2025. There is a consistent high equity ratio averaging around 48%, indicating a strong capital base. However, the increase in total debt over the years suggests a potential leverage risk.

Cash Flow

HUGroup Holdings has seen volatility in its free cash flow, with a significant recovery in 2025 after a negative free cash flow in 2024. The operating cash flow to net income ratio is robust, indicating efficient cash generation relative to net income. However, the fluctuations in free cash flow highlight potential cash management challenges.

Breakdown
Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
243.03B	236.95B	260.91B	272.94B	223.02B
	Gross Profit
66.72B	63.23B	89.92B	111.80B	76.21B
	EBITDA
24.55B	13.65B	43.08B	65.12B	37.89B
	Net Income
2.76B	-7.55B	15.68B	29.60B	17.47B
Balance Sheet		Total Assets
279.58B	290.85B	297.92B	286.59B	252.75B
	Cash, Cash Equivalents and Short-Term Investments
40.88B	39.95B	44.41B	46.71B	43.76B
	Total Debt
86.65B	81.94B	77.16B	73.00B	80.45B
	Total Liabilities
142.28B	148.34B	147.88B	146.41B	137.45B
	Stockholders Equity
137.29B	142.50B	150.04B	140.18B	115.31B
Cash Flow		Free Cash Flow
17.88B	-1.01B	10.85B	20.10B	14.40B
	Operating Cash Flow
21.96B	16.55B	32.53B	55.23B	35.59B
	Investing Cash Flow
-15.96B	-16.05B	-29.58B	-30.86B	-28.27B
	Financing Cash Flow
-5.30B	-5.78B	-5.76B	-21.73B	-1.57B

HUGroup Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3200.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4544, the sentiment is Positive. The current price of 3200 is above the 20-day moving average (MA) of 3094.70, above the 50-day MA of 2921.12, and above the 200-day MA of 2642.04, indicating a bullish trend. The MACD of 66.96 indicates Positive momentum. The RSI at 67.99 is Neutral, neither overbought nor oversold. The STOCH value of 77.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4544.

HUGroup Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4544	63 Neutral	$179.76B	64.80	1.91%	4.00%	2.56%	―
Sector *	48 Neutral	AU$2.46B	3.73	-64.25%	2.94%	35.15%	13.63%
BMZ		€746.27M	19.36	4.86%	3.09%	―	―
4886	76 Outperform	¥64.03B	13.37		2.08%	2.06%	-32.48%
9776	74 Outperform	¥3.46B	6.85		2.26%	2.28%	30.19%
4549	68 Neutral	¥66.26B	31.98		2.60%	1.22%	-8.83%
4671	66 Neutral	¥22.80B	12.50		5.54%	0.71%	19.35%

HUGroup Holdings Corporate Events

H.U. Group Holdings Reports Zero Treasury Stock Acquisition

H.U. Group Holdings announced that it has not acquired any treasury stock as of May 30, 2025, despite a resolution to purchase up to 2.5 million shares by March 31, 2026. This lack of acquisition may impact the company’s market strategy and shareholder value, as the planned repurchase was intended to enhance stock value and optimize capital structure.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Announces Consistent Dividend Payout

H.U. Group Holdings, Inc. has announced a resolution to pay dividends of surplus with a record date of March 31, 2025, maintaining a dividend of 63 yen per share, consistent with the previous fiscal year. This decision underscores the company’s commitment to returning profits to shareholders, aligning with its policy of maintaining stable and consistent dividends.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Announces Strategic Share Repurchase Plan

H.U. Group Holdings, Inc. has announced a strategic move to repurchase its own shares, as part of its new five-year medium-term management plan termed the ‘Investment Harvesting Phase.’ The company aims to enhance shareholder returns with a targeted Dividend on Equity ratio of 6%, and views share repurchases as strategic investments, planning to acquire 2,500,000 common shares through market purchases on the Tokyo Stock Exchange by March 2026.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports Financial Turnaround and Positive Outlook

H.U. Group Holdings reported a notable turnaround in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 2.6% to ¥243,025 million and a return to profitability with a profit attributable to owners of the parent at ¥2,761 million. This marks a significant recovery from the previous fiscal year’s losses, indicating improved operational efficiency and market conditions. The company also forecasts continued growth in the fiscal year ending March 31, 2026, with expected increases in net sales and profits, reflecting a positive outlook for stakeholders.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Revises Earnings Forecast for Fiscal Year 2025

H.U. Group Holdings has revised its full-year consolidated earnings forecast for the fiscal year ending March 31, 2025, due to underperformance in its LTS and IVD businesses. The company expects operating profit to be significantly lower than previously forecasted, influenced by foreign exchange impacts and changes in profit categorization, though the year-end dividend forecast remains unchanged.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.